Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today presented clinical data for CTD402, its investigational allogeneic anti-CD7 CAR ...
Lunsumio in combination with lenalidomide may offer an effective treatment in relapsed or refractory follicular lymphoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback